LifeArc Early Ventures
Funds Seed and Series A equity investment in early-stage life science companies.
LifeArc Early Ventures (LifeArc Ventures) provides Seed and Series A equity investment to early-stage life science companies, with follow-on investment reserved for successful portfolio companies. It invests across therapeutics, HealthTech, and medical devices within LifeArc's five focus areas. This is equity investment, NOT a grant programme. Ticket size, process, and eligibility details are not published on the LifeArc.org page — applicants are directed to the LifeArc Ventures website (lifearcventures.com). As of May 2026 this is listed as the only 'open funding call' on LifeArc's current opportunities page.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.